| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e002d1e6f59681f9e89629025780d569 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8850566ac06bdf9a8a5da0784be41d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0205e5ded9ed4e2c7074ac13d057168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_880a438e849f3ddfda9d94280509fc11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be58d7078c1c6e13b3b3f991e630ac38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cfcaa4503d12d3041df30df51417b8e |
| publicationDate |
2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210102204-A |
| titleOfInvention |
Immunomodulatory polynucleotide conjugates and methods of use |
| abstract |
Provided herein are conjugates for modulating natural killer cells or bone marrow cells comprising a targeting moiety and an immunomodulatory polynucleotide. Also provided herein is a pharmaceutical composition for modulating a natural killer cell or bone marrow cell comprising a conjugate comprising a targeting moiety and an immune modulating polynucleotide and a pharmaceutically acceptable excipient. Further provided herein are methods of using them to modulate natural killer cells or bone marrow cells and to treat proliferative diseases. |
| priorityDate |
2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |